Aptevo Therapeutics reports Q1 results
Source: SeekingAlpha
2026-05-13 09:35:06 ET
More on Aptevo Therapeutics
- Seeking Alpha’s Quant Rating on Aptevo Therapeutics
- Historical earnings data for Aptevo Therapeutics
- Financial information for Aptevo Therapeutics
Read the full article on Seeking Alpha
For further details see:
Aptevo Therapeutics reports Q1 results
Aptevo Therapeutics Inc.
NASDAQ: APVO
APVO Trading
-2.4% G/L:
$4.87 Last:
10,583 Volume:
$5.03 Open:
APVO Latest News
May 28, 2026 08:05:00 am
Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer
May 27, 2026 08:05:00 am
Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Investment by Niowave at Closing
APVO Stock Data
$5,354,805
767,164
N/A
8
N/A
Biotechnology & Life Sciences
Healthcare
US
Seattle
